Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Becton

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Journal of the Arkansas Medical Society|September 28, 2005
Childhood luekemia--success and challengesDavid L Becton
The Journal of the Arkansas Medical Society|September 1, 2009
Bleeding disorders: when is normal bleeding not normal?Kimo C Stine, David L Becton
Journal of Pediatric Hematology/Oncology|April 7, 2007
Use of FEIBA for invasive or surgical procedures in patients with severe hemophilia A or B with inhibitorsKimo C Stine, Dixie Shrum, David L Becton
Medical and Pediatric Oncology|May 24, 2003
Long-term survival in osteosarcoma patients following retinoblastoma using doxorubicin, cisplatin, and methotrexateKimo C Stine, Robert L Saylors, Suzanne Saccente, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 26, 2007
Treatment of deep vein thrombosis with enoxaparin in pediatric cancer patients receiving chemotherapyKimo C Stine, Robert L Saylors, C Suzanne Saccente, et al.
Pediatric Blood & Cancer|June 2, 2004
Efficacy of continuous infusion 2-CDA (cladribine) in pediatric patients with Langerhans cell histiocytosisKimo C Stine, Robert L Saylors, Suzanne Saccente, et al.
Leukemia & Lymphoma|October 31, 2006
CD36 (thrombospondin receptor) expression in childhood acute megakaryoblastic leukemia: in vitro drug sensitivity and outcomeSüreyya Savaşan, Steven Buck, Susana C Raimondi, et al.
Blood|October 27, 2005
Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemiaYubin Ge, Alan A Dombkowski, Katherine M LaFiura, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|November 22, 2013
Cisplatin inhibits bone healing during distraction osteogenesisKimo C Stine, Elizabeth C Wahl, Lichu Liu, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|February 13, 2016
Nutlin-3 treatment spares cisplatin-induced inhibition of bone healing while maintaining osteosarcoma toxicityKimo C Stine, Elizabeth C Wahl, Lichu Liu, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Journal of the Arkansas Medical Society|September 28, 2005
Childhood luekemia--success and challengesDavid L Becton
The Journal of the Arkansas Medical Society|September 1, 2009
Bleeding disorders: when is normal bleeding not normal?Kimo C Stine, David L Becton
Journal of Pediatric Hematology/Oncology|April 7, 2007
Use of FEIBA for invasive or surgical procedures in patients with severe hemophilia A or B with inhibitorsKimo C Stine, Dixie Shrum, David L Becton
Medical and Pediatric Oncology|May 24, 2003
Long-term survival in osteosarcoma patients following retinoblastoma using doxorubicin, cisplatin, and methotrexateKimo C Stine, Robert L Saylors, Suzanne Saccente, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 26, 2007
Treatment of deep vein thrombosis with enoxaparin in pediatric cancer patients receiving chemotherapyKimo C Stine, Robert L Saylors, C Suzanne Saccente, et al.
Pediatric Blood & Cancer|June 2, 2004
Efficacy of continuous infusion 2-CDA (cladribine) in pediatric patients with Langerhans cell histiocytosisKimo C Stine, Robert L Saylors, Suzanne Saccente, et al.
Leukemia & Lymphoma|October 31, 2006
CD36 (thrombospondin receptor) expression in childhood acute megakaryoblastic leukemia: in vitro drug sensitivity and outcomeSüreyya Savaşan, Steven Buck, Susana C Raimondi, et al.
Blood|October 27, 2005
Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemiaYubin Ge, Alan A Dombkowski, Katherine M LaFiura, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|November 22, 2013
Cisplatin inhibits bone healing during distraction osteogenesisKimo C Stine, Elizabeth C Wahl, Lichu Liu, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|February 13, 2016
Nutlin-3 treatment spares cisplatin-induced inhibition of bone healing while maintaining osteosarcoma toxicityKimo C Stine, Elizabeth C Wahl, Lichu Liu, et al.
Pageof 2